mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.008 |
mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
-0.41 |
0.008 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.009 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |